Lijing Wang

1.9k total citations
66 papers, 1.2k citations indexed

About

Lijing Wang is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Lijing Wang has authored 66 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 15 papers in Immunology and 14 papers in Cancer Research. Recurrent topics in Lijing Wang's work include Angiogenesis and VEGF in Cancer (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Axon Guidance and Neuronal Signaling (5 papers). Lijing Wang is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Axon Guidance and Neuronal Signaling (5 papers). Lijing Wang collaborates with scholars based in China, United States and United Kingdom. Lijing Wang's co-authors include Cuiling Qi, Jiangchao Li, Lingyun Zheng, Qiong Chen, Qianqian Zhang, Bo Wei, Yu Qiao, Tian Lan, Jian Xiao and Sun‐Wei Guo and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lijing Wang

63 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lijing Wang China 20 668 299 182 178 126 66 1.2k
Yingsong Wu China 19 667 1.0× 285 1.0× 219 1.2× 175 1.0× 104 0.8× 55 1.2k
Weibin Wu China 22 704 1.1× 246 0.8× 179 1.0× 202 1.1× 111 0.9× 88 1.4k
Hong Shu China 22 780 1.2× 309 1.0× 134 0.7× 245 1.4× 177 1.4× 94 1.4k
Xiaoqi Wang China 22 905 1.4× 248 0.8× 318 1.7× 245 1.4× 119 0.9× 66 1.4k
Ying Zheng China 21 556 0.8× 233 0.8× 152 0.8× 166 0.9× 127 1.0× 43 1.1k
Srinivas Chava United States 20 614 0.9× 400 1.3× 118 0.6× 154 0.9× 73 0.6× 41 1.2k
Lijuan Hu China 23 793 1.2× 316 1.1× 188 1.0× 248 1.4× 97 0.8× 112 1.5k
Tomoko Inoue Japan 19 565 0.8× 200 0.7× 175 1.0× 286 1.6× 62 0.5× 50 1.0k
Tao Huang China 24 1.0k 1.5× 560 1.9× 140 0.8× 133 0.7× 96 0.8× 115 1.8k

Countries citing papers authored by Lijing Wang

Since Specialization
Citations

This map shows the geographic impact of Lijing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijing Wang more than expected).

Fields of papers citing papers by Lijing Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijing Wang. The network helps show where Lijing Wang may publish in the future.

Co-authorship network of co-authors of Lijing Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lijing Wang. A scholar is included among the top collaborators of Lijing Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijing Wang. Lijing Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Qiao, Jian Chen, Yi Ding, et al.. (2023). CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth. BMC Cancer. 23(1). 6 indexed citations
3.
Liu, Ying, Cuiling Qi, Lingyun Zheng, et al.. (2021). 1H-NMR based metabolic study of MMTV-PyMT mice along with pathological progress to screen biomarkers for the early diagnosis of breast cancer. Molecular Omics. 18(2). 167–177. 1 indexed citations
4.
Wang, Lijing, et al.. (2021). Cigarette smoke extract-treated airway epithelial cells-derived exosomes promote M1 macrophage polarization in chronic obstructive pulmonary disease. International Immunopharmacology. 96. 107700–107700. 40 indexed citations
5.
Li, Junchen, Yi Ding, Yuying Yao, et al.. (2021). Andrographolide Suppresses the Growth and Metastasis of Luminal-Like Breast Cancer by Inhibiting the NF-κB/miR-21-5p/PDCD4 Signaling Pathway. Frontiers in Cell and Developmental Biology. 9. 643525–643525. 31 indexed citations
6.
Zhong, Mei, Janak L. Pathak, Hongbin Gao, et al.. (2020). ACE2 and Furin Expressions in Oral Epithelial Cells Possibly Facilitate COVID-19 Infection via Respiratory and Fecal–Oral Routes. Frontiers in Medicine. 7. 580796–580796. 62 indexed citations
7.
Wang, Sheng, et al.. (2019). Gastric precancerous lesions present in ApcMin/+ mice. Biomedicine & Pharmacotherapy. 121. 109534–109534. 4 indexed citations
8.
Lu, Xiaoxiao, Bixiu He, Ge Wang, et al.. (2017). Bronchoscopic Diagnosis and Treatment of Primary Tracheobronchial Amyloidosis: A Retrospective Analysis from China. BioMed Research International. 2017. 1–7. 13 indexed citations
9.
Zhang, Qianqian, Jian Chen, Da‐Lei Zhou, et al.. (2017). Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer. International Journal of Biological Sciences. 13(4). 471–479. 11 indexed citations
10.
Qi, Cuiling, Bin Li, Yang Yang, et al.. (2016). Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis. Scientific Reports. 6(1). 27819–27819. 25 indexed citations
11.
Wu, Li, Xiaoying Liu, Yanping Wang, et al.. (2016). Exendin-4 protects HUVECs from tunicamycin-induced apoptosis via inhibiting the IRE1a/JNK/caspase-3 pathway. Endocrine. 55(3). 764–772. 17 indexed citations
12.
Li, Jiangchao, Hong Yang, Yan Li, et al.. (2014). microRNA-146 up-regulation predicts the prognosis of non-small cell lung cancer by miRNA in situ hybridization. Experimental and Molecular Pathology. 96(2). 195–199. 36 indexed citations
13.
Wang, Lijing. (2013). Effect of Slit2 on the development of DMH/DSS-induced mouse colorectal cancer. 1 indexed citations
14.
Wang, Lijing. (2013). Inhibitory effect of andrographolide on cell proliferation of glioblastoma U87 cells and its mechanism. Journal of Jilin University. 1 indexed citations
15.
Li, Jiangchao, Xiaodong Li, Yan Li, et al.. (2013). Cell-Specific Detection of miR-375 Downregulation for Predicting the Prognosis of Esophageal Squamous Cell Carcinoma by miRNA In Situ Hybridization. PLoS ONE. 8(1). e53582–e53582. 58 indexed citations
16.
Wang, Lijing, et al.. (2013). Characterization and Fine Mapping of a Necrotic Leaf Mutant in Maize (Zea mays L.). Journal of genetics and genomics. 40(6). 307–314. 11 indexed citations
17.
Wang, Lijing. (2011). Reduning treatment of children with herpes angina efficacy. China Medical Herald. 5 indexed citations
18.
Tang, Futian, Jiao Guo, Wei He, et al.. (2011). Effects of Fufang Zhenzhu Tiaozhi Prescription (复方贞术调脂方), A Chinese herbal preparation, on atherosclerosis in ApoE-/- mice and related mechanisms. Chinese Journal of Integrative Medicine. 14 indexed citations
19.
Mao, Jianwen, Lixin Chen, Bin Xu, et al.. (2008). Suppression of ClC-3 channel expression reduces migration of nasopharyngeal carcinoma cells. Biochemical Pharmacology. 75(9). 1706–1716. 71 indexed citations
20.
Wang, Lijing, et al.. (2003). [Relation of heparanase mRNA expression and angiogenesis to the progression of gastric carcinoma].. PubMed. 25(4). 368–71. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026